Clinical trial
A European Multicentre Double-blind Placebo-controlled Phase III Trial of Nilvadipine in Mild to Moderate Alzheimer's Disease
NCT02017340 is registered in ClinicalTrials.gov with Prof Brian Lawlor as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A European Multicentre Double-blind Placebo-controlled Phase III Trial of Nilvadipine in Mild to Moderate Alzheimer's Disease
- Lead sponsor
- Prof Brian Lawlor
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- April 24, 2013
- Completion date
- December 16, 2016
- Enrollment
- 511 (actual)
- Sites
- 23
Conditions
As the registry lists them; a condition with its own page is linked.
alzheimer's disease